Recommended Actions

To ensure a more effective response to viral hepatitis, we recommend the next elected Australian Government implements the following actions as soon as possible.

  1. Provide additional Federal funding to effectively implement the National Hepatitis B Strategy;
  2. Introduce targets for hepatitis B testing and treatment and monitor these through new indicators in the National Health Reform Agreements;
  3. Provide Federal funding for hepatitis B awareness and testing programs targeting people from high-prevalence migrant communities and Aboriginal and Torres Strait Islander peoples;
  4. Redistribute existing Federal funding for hepatitis B awareness and early clinical intervention programs to support increased monitoring and treatment access for people from high-prevalence migrant communities and Aboriginal and Torres Strait Islander peoples;
  5. Expand Federal funding for hepatitis B vaccination programs to ensure national consistency and include every adolescent and adult at higher risk of infection;
  6. Ensure that accessibility to needle and syringe programs matches demand and does not dissipate over time;
  7. Increase accountability of Federal funds allocated for the delivery of needle and syringe programs at the State and Territory level;
  8. Commit to fast-tracking the approval process for new hepatitis C medicines through the Pharmaceutical Benefits Advisory Committee to ensure the prompt listing of new hepatitis C medicines on the Pharmaceutical Benefits Scheme; 
  9. Introduce measurable targets for hepatitis C treatment together with appropriate monitoring and robust accountability systems; and
  10. Fund the development of best practice, multi-disciplinary and holistic care pathways that are inclusive of new forms of treatment and responsive to the needs of people with hepatitis C.